Atea Pharmaceuticals, Inc.
AVIR
$5.27
-$0.41-7.22%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 219.47M | 256.01M | 301.83M | 329.31M | 379.71M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 9.20M | 7.19M | 9.16M | 6.83M | 5.89M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 228.67M | 263.20M | 310.99M | 336.14M | 385.60M |
|
|
|||||
| Total Current Assets | 228.67M | 263.20M | 310.99M | 336.14M | 385.60M |
| Net Property, Plant & Equipment | 569.00K | 831.00K | 1.09M | 1.35M | 1.61M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 3.05M | 3.05M | 3.14M | 5.48M | 4.39M |
| Total Assets | 232.28M | 267.08M | 315.22M | 342.96M | 391.61M |
|
|
|||||
| Total Accounts Payable | 10.06M | 9.45M | 12.95M | 3.52M | 8.84M |
| Total Accrued Expenses | 17.64M | 23.29M | 26.00M | 15.83M | 10.45M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 424.00K | 634.00K | 843.00K | 832.00K | 821.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 28.12M | 33.37M | 39.78M | 20.18M | 20.12M |
|
|
|||||
| Total Current Liabilities | 28.12M | 33.37M | 39.78M | 20.18M | 20.12M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | 213.00K | 425.00K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | 6.80M | 6.65M |
| Total Liabilities | 28.12M | 33.37M | 39.78M | 27.18M | 27.19M |
|
|
|||||
| Common Stock & APIC | 805.20M | 801.82M | 797.83M | 793.24M | 800.03M |
| Retained Earnings | -600.94M | -568.01M | -522.57M | -477.70M | -435.65M |
| Treasury Stock & Other | -96.00K | -97.00K | 174.00K | 238.00K | 37.00K |
| Total Common Equity | 204.16M | 233.71M | 275.43M | 315.78M | 364.42M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 204.16M | 233.71M | 275.43M | 315.78M | 364.42M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 204.16M | 233.71M | 275.43M | 315.78M | 364.42M |
|
|
|||||